ScholarIQanswers from OpenAlex
Vitality Institute
InstitutionResearch output, impact & collaborations
Vitality Institute is a institution indexed in ScholarIQ from OpenAlex.
What is known about Vitality Institute?
ScholarIQrecord summary
Vitality Institute is a research organisation in New York, US. OpenAlex records 598 works and 13,045 citations for it. 155 researchers list it as their most recent affiliation.
How many works does Vitality Institute have?
ScholarIQindexed works
Vitality Institute has 598 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Vitality Institute have?
ScholarIQcitation count
Vitality Institute has 13,045 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Vitality Institute?
ScholarIQresearcher count
Vitality Institute has 155 researchers in the ScholarIQ index.
What is the average h-index at Vitality Institute?
ScholarIQavg h-index
Vitality Institute has an average h-index of 78 in OpenAlex.
What is the ROR of Vitality Institute?
ScholarIQror
The ROR for Vitality Institute is on the source record.
What is the OpenAlex record for Vitality Institute?
ScholarIQopenalex
The OpenAlex for Vitality Institute is on the source record.
Who are the most-cited researchers behind Vitality Institute?
ScholarIQtop researchers by citations
What are the most-cited papers on Vitality Institute?
ScholarIQmost cited works
A polymorphic DNA marker genetically linked to Huntington's disease
James F. Gusella, Nancy S. Wexler, P. Michael Conneally, Susan L. Naylor, Mary Anne Anderson, Rudolph E. Tanzi, Paul C. Watkins, Kathleen Ottina, Margaret R. Wallace, Alan Y. Sakaguchi, Anne B. Young, Ira Shoulson, Ernesto Bonilla, Joseph B. Martin
Variable expression of Parkinson's disease
Joseph Jankovic, Michael McDermott, Jonathan Carter, Serge Gauthier, Christopher G. Goetz, Lawrence I. Golbe, S. J. Huber, William C. Koller, C. Warren Olanow, Ira Shoulson, Matthew Stern, Caroline M. Tanner, William J. Weiner, Parkinson Study Group
Detection of Huntington's disease decades before diagnosis: the Predict-HD study
Jane S. Paulsen, Douglas R. Langbehn, Julie C. Stout, Elizabeth Aylward, C A Ross, Martha Nance, Mark Guttman, S Johnson, Marcy E. MacDonald, Leigh J. Beglinger, Karen Duff, Elise Kayson, Kevin Biglan, Ira Shoulson, David Oakes, Michael R. Hayden, The Predict-HD Investigators and Coordinators of the Huntington Study Group
A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease
The Parkinson Study Group QE3 Investigators, M. Flint Beal, David Oakes, Ira Shoulson, Claire Henchcliffe, Wendy R. Galpern, Richard Haas, Jorge L. Juncos, John G. Nutt, Tiffini Voss, Bernard Ravina, Clifford M. Shults, Karen Helles, Victoria Snively, Mark Lew, Brian Griebner, Arthur Watts, Shan Gao, Emmanuelle Pourcher, Louisette Bond, Katie Kompoliti, Pinky Agarwal, Cherissa Sia, Mandar Jog, Linda Cole, Munira Sultana, Roger Kurlan, Irene Hegeman Richard, Cheryl Deeley, Cheryl Waters, Angel Figueroa, Ani Arkun, Matthew Brodsky, William G. Ondo, Christine Hunter, Joohi Jimenez‐Shahed, Alicia Palao, Janis M. Miyasaki, Julie So, James W. Tetrud, Liza Reys, Katharine Smith, Carlos Singer, Anita Blenke, David Russell, Candace Cotto, Joseph H. Friedman, Margaret C. Lannon, Lin Zhang, Edward Drasby, Rajeev Kumar, Thyagarajan Subramanian, Donna Stuppy Ford, David A. Grimes, Diane Côté, Jennifer Conway, Andrew Siderowf, Marian L. Evatt, Barbara Sommerfeld, Abraham Lieberman, Michael S. Okun, Ramon L. Rodriguez, Stacy Merritt, Camille Swartz, W. R. Wayne Martin, Pamela King, Natividad Stover, Stephanie Guthrie, Ray L. Watts, Anwar Ahmed, Hubert H. Fernandez, Adrienna Winters, Zoltán Mari, Ted M. Dawson, Becky Dunlop, Andrew Feigin, Barbara Shannon, Melissa J. Nirenberg, Mattson Ogg, Samuel A. Ellias, Cathi-Ann Thomas, Karen Frei, Iván Bódis-Wollner, Sofya Glazman, Thomas A. Mayer, Robert A. Hauser, Rajesh Pahwa, April Langhammer, Ranjit Ranawaya, Lorelei Derwent, Kapil D. Sethi, Buff Farrow, Rajan Prakash, Irene Litvan, Annette Robinson, Alok Sahay, Maureen Gartner, Vanessa K. Hinson, Samuel Markind, Melisa Pelikan
Development of a New Once-a-Day Formulation of Methylphenidate for the Treatment of Attention-deficit/Hyperactivity Disorder
James M. Swanson, Suneel Gupta, Andrew Lam, Ira Shoulson, Marc Lerner, Nishit B. Modi, Elizabeth Lindemulder, Sharon B. Wigal
How much of the research on Vitality Institute is open access?
ScholarIQopen access share
43%OPEN ACCESS